If ADO wants to avoid another CR at the end of the next two quarters then it has a few options.
1. Creative finance like your example.
2. Off load the short fall at 0.02 cents to a major partner or investor.
3. Sell an equity stake to a major partner.
Option 3 has been mentioned by David a few times and the Serum Institute of India would be a good fit IMO.
Whatever happens a CR would be the worst option to take.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.00%) |
Mkt cap ! $32.46M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $48.27K | 3.819M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 593080 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1500000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| ADO (ASX) Chart |